Effect of Injectable Hyaluronic Acid (HYADENT BG (HA)) on Bone Healing in Extraction Sockets
2 other identifiers
interventional
20
1 country
1
Brief Summary
Complications such as postoperative pain and delayed socket healing are relatively common following surgical extraction of mandibular third molars. Various biomaterials have been investigated to enhance wound healing and reduce postoperative morbidity. Hyaluronic acid (HA) has demonstrated anti-inflammatory and regenerative properties that may improve both soft and hard tissue healing. The aim of this study is to evaluate the effect of topical hyaluronic acid on postoperative pain and alveolar socket bone healing following surgical extraction of mandibular third molars. A prospective, randomized, controlled clinical trial with a split-mouth design will be conducted. Twenty patients requiring bilateral mandibular third molar surgical extraction will be enrolled. In each patient, one extraction socket will receive hyaluronic acid combined with a collagen sponge, while the contralateral socket will receive a collagen sponge alone, according to random allocation. Postoperative pain will be assessed using a visual analogue scale, and socket healing will be evaluated radiographically and histologically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedJanuary 28, 2026
January 1, 2026
1.6 years
August 25, 2025
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative Pain Intensity
Postoperative pain intensity will be assessed using a visual analogue scale (VAS) ranging from 1 (no pain) to 10 (worst pain imaginable). Participants will record pain scores at standardized time points following mandibular third molar extraction.
12 hours (postoperative day 1), postoperative day 3, and postoperative day 7. Units of measure is VAS score (1-10).
Alveolar Socket Bone Healing
Alveolar socket bone healing will be evaluated histologically by quantifying the percentage of woven bone formation within the extraction socket. Core biopsies will be obtained six weeks post-extraction and analyzed using digital histomorphometry. The percentage of woven bone area within predefined regions of interest will be calculated using ImageJ software.
6 weeks after tooth extraction. units of measure is percentage of woven bone area (%)
Other Outcomes (1)
Radiographic Assessment of Socket Healing
Preoperative baseline and 6-8 weeks post-extraction
Study Arms (2)
placebo extraction side
PLACEBO COMPARATORSurgical extraction of wisdom tooth with placebo administration inside the extraction site using collagen sponge
experimental extraction side
EXPERIMENTALSurgical extraction of wisdom tooth with placebo administration inside the extraction site using hyaluronic acid gel
Interventions
A standardized surgical procedure was performed by a single experienced surgeon (ZA). Under strict aseptic conditions, an inferior alveolar nerve block with buccal infiltration, was given using lidocaine HCl 2% with epinephrine 1:100,000 (Cook-Waite, Rochester, NY). A mucoperiosteal envelope flap was utilized for all surgeries. Bone removal and tooth sectioning were performed as deemed necessary using a low-speed handpiece under copious saline irrigation. After tooth removal, HA gel (Hyadent) was placed inside the extraction socket and covered with collagen sponge in the test sockets, while only coverage with collagen sponge was placed in the control sockets. Subsequently, flap closure was achieved using 3-0 silk sutures
After 6 weeks, core biopsies are taken from both sides. Under local anesthesia, the core biopsies sre taken without reflection of a flap, using a graded trephine bur (MCT, Korea) of 3 mm diameter (which is not invasive or having any complication) for later histological evaluation. Specimens harvested from each patient are fixed in 10% formalin, then decalcified using 10% hydrochloric acid. After processing, 5 micrometer sections are prepared and stained with hematoxylin and eosin stain (H\&E). Digital images are acquired from each section at a magnification of Ă— 40. ImageJ 1.52a software (National Institute of Health, Bethesda, Maryland, USA) is used to calculate the percentage of woven bone area within selected regions of interest (ROI) in each image, utilizing the color thresholding feature. To ensure that measurements are valid, 3 measurements are made for each of the hard tissue and soft tissue components, and for the total area of the ROI in pixels.
Eligibility Criteria
You may qualify if:
- Male and female participants aged 18 to 35 years
- Presence of bilateral impacted mandibular third molars classified as Pell and Gregory Class II, Position B
- Classified as American Society of Anesthesiologists (ASA) Physical Status I
- Absence of active local infection at the surgical site (e.g., no swelling, trismus, hyperthermia)
- Ability to maintain adequate oral hygiene
- Ability to understand and provide written informed consent
- Ability to read and understand Arabic or English
- Willingness to comply with study procedures and follow-up visits
You may not qualify if:
- History of systemic diseases such as diabetes mellitus, hypertension, gastric ulcer, or other significant medical conditions
- Presence of severe or chronic illness requiring frequent hospitalization
- Pregnant or breastfeeding individuals
- History of cognitive or motor impairment that may interfere with study participation
- Use of anti-inflammatory or analgesic medications within two weeks before surgery
- Known allergy or hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)
- Current smoker
- Use of anticoagulant therapy
- Any condition that, in the investigator's judgment, may interfere with healing or study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Higher specialty training center
Irbid, 11196, Jordan
Related Publications (1)
Domic D, Bertl K, Lang T, Pandis N, Ulm C, Stavropoulos A. Hyaluronic acid in tooth extraction: a systematic review and meta-analysis of preclinical and clinical trials. Clin Oral Investig. 2023 Dec;27(12):7209-7229. doi: 10.1007/s00784-023-05227-4. Epub 2023 Nov 15.
PMID: 37963982BACKGROUND
Study Officials
- STUDY CHAIR
Rola Habashneh, Professor
Jordan University of Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double (Participant, Investigator)
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2025
First Posted
January 5, 2026
Study Start
August 1, 2024
Primary Completion
February 26, 2026
Study Completion
April 30, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The data of the participants collected are clinical and we should take their consent for any future studies. As our IRB approval is limited to this study, we cant share these data.